Top Page
Tate & Lyle
(LSE:TATE)
Tate & Lyle (TATE) vs. iShares MSCI United Kingdom ETF (EWC)
Tate & Lyle Business Overview & Revenue Model
Tate & Lyle Earnings Call Summary
Tate & Lyle Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.56B | 1.74B | 1.65B | 1.75B | 1.38B | 1.21B |
| Gross Profit | 1.56B | 706.00M | 851.00M | 733.00M | 514.00M | 481.00M |
| EBITDA | 338.00M | 254.00M | 345.00M | 279.00M | 168.00M | 292.00M |
| Net Income | 251.00M | 143.00M | 188.00M | 190.00M | 236.00M | 253.00M |
Balance Sheet | ||||||
| Total Assets | 2.21B | 3.73B | 2.28B | 2.51B | 3.25B | 2.97B |
| Cash, Cash Equivalents and Short-Term Investments | 594.00M | 334.00M | 437.00M | 475.00M | 112.00M | 371.00M |
| Total Debt | 555.00M | 1.31B | 590.00M | 713.00M | 679.00M | 786.00M |
| Total Liabilities | 1.02B | 2.14B | 1.04B | 1.32B | 1.63B | 1.51B |
| Stockholders Equity | 1.19B | 1.59B | 1.24B | 1.19B | 1.62B | 1.45B |
Cash Flow | ||||||
| Free Cash Flow | 171.00M | 43.00M | 98.00M | -12.00M | -45.00M | 217.00M |
| Operating Cash Flow | 282.00M | 164.00M | 208.00M | 66.00M | 103.00M | 369.00M |
| Investing Cash Flow | 176.00M | -630.00M | -20.00M | 835.00M | -113.00M | -205.00M |
| Financing Cash Flow | -154.00M | 367.00M | -215.00M | -598.00M | -247.00M | -29.00M |
Tate & Lyle Technical Analysis
Tate & Lyle Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | £16.22B | 12.86 | 11.89% | 2.75% | -0.38% | 14.68% | |
| ― | £2.64B | 19.71 | 14.14% | 2.05% | 4.77% | 18.94% | |
| ― | £1.57B | 12.73 | 9.02% | 1.54% | 1.01% | 11.12% | |
| ― | £1.02B | 19.37 | 12.12% | 0.85% | 0.49% | 14.18% | |
| ― | £574.45M | 14.68 | 12.72% | 5.43% | 8.58% | -15.81% | |
| ― | £1.71B | 27.25 | 3.39% | 5.13% | 5.40% | -67.46% | |
| ― | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
Tate & Lyle Corporate Events
Tate & Lyle PLC announced a transaction involving the acquisition of 16,000 ordinary shares by Steve Foots, a Person Discharging Managerial Responsibilities, and Alison Foots, a person closely associated. This transaction, conducted on the London Stock Exchange at a price of £3.699547 per share, aligns with the company’s compliance with the Market Abuse Regulation and reflects the confidence of its management in the company’s future prospects.
The most recent analyst rating on (GB:TATE) stock is a Buy with a £4.60 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC announced a transaction involving Claudia Vaz de Lestapis, a non-executive director, and Alexandre Samuel Pierre Marie de Lestapis, who acquired 2,500 American Depositary Receipts (ADRs) at a price of US$20.16 each. This acquisition increases their total holding to 5,000 ADRs, equivalent to 20,000 ordinary shares, and was conducted on the OTCQX exchange. This transaction reflects the confidence of key stakeholders in the company’s future prospects and complies with the Market Abuse Regulation.
The most recent analyst rating on (GB:TATE) stock is a Buy with a £4.60 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC announced a significant transaction involving its CEO, Nick Hampton, who acquired 25,000 ordinary shares at a price of £3.688 each, increasing his total shareholding to 951,816 shares. This transaction, conducted on the London Stock Exchange, highlights a vote of confidence in the company’s future prospects by its leadership, potentially impacting investor perceptions and market positioning.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £4.30 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC announced that Glenn Fish, a non-executive director and person discharging managerial responsibilities, acquired 1,000 American Depositary Receipts (ADRs) at a price of US$20.50 each. This transaction, conducted on the OTCQX exchange, increases Mr. Fish’s total interest to 5,049.828 ADRs, representing 20,199.3 shares in the company. The acquisition reflects a strategic move by a key company figure, potentially signaling confidence in the company’s future performance and stability.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £4.30 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC has issued a pre-close statement ahead of its six-month results announcement, highlighting strong customer engagement and early cross-selling successes following its combination with CP Kelco. Despite a slowdown in market demand impacting short-term financial performance, the company is accelerating efforts to drive top-line growth through enhanced customer segmentation and innovation. The integration with CP Kelco is expected to deliver revenue and cost synergies, positioning Tate & Lyle for improved performance in the future, despite current economic volatility.
The most recent analyst rating on (GB:TATE) stock is a Buy with a £6.50 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC has announced its current issued share capital as of August 29, 2025, which consists of 476,741,354 ordinary shares, with 31,294,579 held in Treasury. This results in a total of 445,446,775 voting rights, which shareholders can use to assess their interests in the company under the Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £577.00 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC announced a transaction involving Glenn Fish, a Non-executive Director, who acquired 89.424 American Depositary Receipts (ADRs) at a price of US$29.31 each, representing an interest in 16,199.3 shares of the company. This transaction, conducted on the OTCQX exchange, reflects managerial confidence in the company’s prospects and complies with the Market Abuse Regulation, potentially impacting stakeholder perceptions positively.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £7.25 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC announced a transaction involving Claudia Vaz de Lestapis, a non-executive director, and Alexandre Samuel Pierre Marie de Lestapis, who acquired 2,500 American Depositary Receipts (ADRs) at a price of $28.84 each, representing an interest in 10,000 ordinary shares of the company. This transaction, conducted on the OTCQX exchange, reflects the ongoing engagement of key company figures in its financial instruments, potentially signaling confidence in the company’s market position and future prospects.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £7.25 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC has announced its issued share capital as of July 31, 2025, consisting of 476,739,802 ordinary shares, with 31,294,579 held in Treasury and not carrying voting rights. The total number of voting rights available is 445,445,223, which shareholders can use to determine their interest in the company under the Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:TATE) stock is a Buy with a £1000.00 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
At the 2025 Annual General Meeting, Tate & Lyle PLC announced that all proposed resolutions were passed, including the approval of the Directors’ Remuneration Policy and Report. Notably, 24.19% of shareholders voted against the Directors’ Remuneration Report, prompting the Board to engage further with shareholders to address concerns. The company will provide an update within six months, aligning with the UK Corporate Governance Code.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £7.25 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.